Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 448.6 Million | USD 1,162.40 Million | CAGR at 11.28% | 2023 |
According to the report published by Zion Market Research, the global Commercial Aquaculture Vaccines Market size was valued at USD 448.6 Million in 2023 and is predicted to reach USD 1,162.40 Million by the end of 2032. The market is expected to grow with a CAGR of 11.28% during the forecast period. The report analyzes the global Commercial Aquaculture Vaccines Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Commercial Aquaculture Vaccines Market industry.
Aquaculture vaccine is a kind of farming for aquatic animals. The process involves rearing, breeding, and harvesting aquatic animals for consumption purposes. Vaccination enhances the survival rate and increases the profitability of aquaculture production.
One of the major factors driving the growth of the global commercial aquaculture vaccines market is the growing transformation of conventional antibiotic treatment to vaccine preventive measures. Conventionally, antibiotics were widely used but excessive dosages led to the potential risk of dissemination and bacterial resistance among the consumers of these aquatic animals.
The growing prevalence of viral and bacterial infections among fish species all over the world is fuelling the growth of the global market significantly. However, the rapid proliferation of aquaculture production is the primary factor contributing significantly to the growth of the global market. The significant spike in the adoption of vaccines by aquaculture farmers has fueled the demand in the market globally. The growing restrictions and regulations on the antibiotic used in aquaculture vaccines have also propelled the adoption rate of aquaculture vaccines.
The emergence of technologically advanced subunit vaccines along with the introduction of DNA has bolstered the growth of the global commercial aquaculture vaccines market. Moreover, the innovation of novel and advanced vaccines for treating viral and bacterial infections during the process of fish farming is likely to propel the growth of the global market during the forecast period.
The manufacturers are concentrating on launching new and effective vaccines for complex bacterial infections like viruses and pasteurellosis to boost the demand for aquaculture vaccines all across the globe. Moreover, the growing funding and research & development programs to innovate new vaccines are expected to drive the growth of the global commercial aquaculture vaccines market significantly during the forecast period.
The global commercial aquaculture vaccines market can be segmented into type, route of administration, species, application, and region.
By type, the market can be segmented into live and inactive vaccines. The inactive vaccines segment dominates the global market. The growth can be attributed to the effective method used to kill the pathogens. Moreover, there is a very low risk of pathogen re-emergence.
By route of administration, the market can be segmented into oral vaccines, injection vaccines, and immersion vaccines. The immersion vaccines segment holds the largest share in the global commercial aquaculture vaccines market. These vaccines assist immune cells present in fish gills directly exposed to antigens.
By application, the market can be segmented into viral infection and bacterial infection. The bacterial infection segment accounts for the largest share in the global commercial aquaculture vaccines market owing to the high prevalence of dangerous diseases like yersiniosis. Some of the gram-positive bacteria include Streptococcus spp, Edwardsiella ictaluri, E Tarda, Vibrio spp, Aeromonas hydrophila, and A Salmonicida. The viral infection segment is also expected to grow significantly during the forecast period.
By species, the market can be segmented into tilapia, trout, salmon, and others.
Report Attributes | Report Details |
---|---|
Report Name | Commercial Aquaculture Vaccines Market Research Report |
Market Size in 2023 | USD 448.6 Million |
Market Forecast in 2032 | USD 1,162.40 Million |
Growth Rate | CAGR of 11.28% |
Number of Pages | 201 |
Key Companies Covered | Nittan Valve Co., Ltd., Nanjing Superior Machine & Parts Co, Melling, LuK GmbH & Co. KG, LISI Automotive, Kent Automotive, ITW Automotive, Indo Schottle Pvt. Ltd, Hangzhou Heng Ji Trading Co., Ltd., GT Technologies, Federal-Mogul, EFC International, Eaton, DREWCO Corporation, DNJ Engine Components, Decora Auto Forge Pvt. Ltd., Burgess-Norton Mfg. Co. Inc, AmTech International, and ACDelco |
Segments Covered | By Type, By Route of administration, By species, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific accounts for the largest share in the global market owing to the rapidly increasing aquaculture sector coupled with developments in the vaccine. Moreover, the growing prevalence of diseases like hepatopancreatic microsporidiosis, acute hepatic necrosis, and others has also boosted the growth of the regional market.
North America accounts for the second-largest share in the global commercial aquaculture vaccines market due to the growing investment to boost the research and development activities in aquaculture vaccines to innovate effective drugs.
Some of the significant players in the global commercial aquaculture vaccines market are:
The Global Commercial Aquaculture Vaccines Market is segmented as follows:
By Type
By Route of administration
By species
By Application
FrequentlyAsked Questions
One of the major factors driving the growth of the global commercial aquaculture vaccines market is the growing transformation of conventional antibiotic treatment to vaccine preventive measures. Conventionally, antibiotics were widely used but excessive dosages led to the potential risk of dissemination and bacterial resistance among the consumers of these aquatic animals. The growing prevalence of viral and bacterial infections among fish species all over the world is fuelling the growth of the global market significantly.
Some of the significant players in the global commercial aquaculture vaccines market are Kennebec River Biosciences, Sanphar, Intervet-International BV, AniCon Labor GmbH, HIPRA, Barramundi Asia Pte Ltd., Vaxxinova, Zoetis, Ceva Biovac, MARINNOVAC, IDT Biologika GmbH, Tecnovax, and Hipra.
Asia Pacific accounts for the largest share in the global market owing to the rapidly increasing aquaculture sector coupled with developments in the vaccine. Moreover, the growing prevalence of diseases like hepatopancreatic microsporidiosis, acute hepatic necrosis, and others has also boosted the growth of the regional market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed